Join the Beacon Asia Tour - Kicking Off May 19th!
Learn More

On-Demand Webinars

See how industry pioneers are revealing the true immune biology at each development stage.

Optofluidic
Speaker: Joseph Zenga, MD, Associate Professor & Vice-Chair of Research, Cancer Center, Medical College of Wisconsin | Anthony E. Zamora, PhD, Assistant Professor, Medicine (Hematology and Oncology), Medical College of Wisconsin | Yan Zhang, PhD, President, Bruker Cellular Analysis | Vikram (Vik) Devgan, PhD, VP of Global Marketing, Bruker Cellular Analysis
Introducing Beacon Discoveryโ„ข: Live Single Cells. Deepest Functional Insights.
Optofluidic
Speaker: Colby Souders, Ph.D., CSO, Twist Biopharma Solutions | Brian Walters, CEO, Genovac | Vincent Pai, Director of Product Management, Bruker Cellular Analysis
Antibody Discovery in 2025: How Industry Leaders are Adapting to Market Trends, Technological Innovations, and Economic Pressures
Optofluidic
Speaker: Iwona Budnicki, Ph.D., Manager, Cellular Immunology, Genovac | Donovan McGinley-Colman, Senior Scientist, Genovac | Danielle Borys, Senior Product Applications Scientist, Bruker Cellular Analysis
Strategic Use of Advanced Technologies and Multiple Host Species to Rapidly Generate Cost-Effective Antibody Candidates
Optofluidic
Speaker: Colby Souders, Ph.D., CSO, Twist Biopharma Solutions | Vincent Pai, Director of Product Management, Bruker Cellular Analysis
A Meta-Analysis of 150+ Antibody Discovery Campaigns: Transgenic Mouse Performance Against Single B Cell Technology Trends
Optofluidic
Speaker: Denny May, PhD, Scientific Liaison, Bruker Cellular Analysis | Leigh Ann Fall, MS, Senior Product Applications Scientist, Bruker Cellular Analysis
Next-Level T Cell Analysis: Discovering Function, Biomarkers, and Therapeutic Potential
Optofluidic
Speaker: Or Gadish, Ph.D. Senior Manager, Applications Research and Development Engineering, Bruker Cellular Analysis | Eric Sackmann, Ph.D. Director of Product Management, Bruker Cellular Analysis
The Physics and Technology Underlying the Beacon Platform for Cell Line Development
Optofluidic
Speaker: Holly Corrigall, Head of Cell Line Development, GSK
Light Boxes and Beyond: Maximizing Confidence in Clone Selection Using the Beacon Optofluidic System
Optofluidic
Speaker: Eric Sackmann, Ph.D., Director, Product Management, Bruker Cellular Analysis
Harnessing the Power of the Beacon Platform to Accelerate Cell Line Development Workflows
Optofluidic
Speaker: Vincent Pai, Director, Product Management, Bruker Cellular Analysis | Yu Liang, VP of Ab Drug Discovery, GenScript ProBio
Accelerating Therapeutic Antibody Discovery: Innovative Technologies Transforming Hit Generation and Lead Characterization
Optofluidic
Speaker: Dr. Michael Wilson, Professor of Neurology, University of California, San Francisco
Autoantibody Discovery in Neuroinflammatory Disease
Optofluidic
Speaker: Vincent Pai, Director of Product Management, Bruker Cellular Analysis
Autoantibody Discovery on the Beaconยฎ Platform
Optofluidic
Speaker: Joseph Zenga, MD, Associate Professor, Division Chief, Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin
Advancing Single-Cell Methods in Solid Tumor Oncology with Brukerโ€™s Optofluidic Platform
Optofluidic
Speaker: Edward Han, PhD, Product Manager, Bruker Cellular Analysis
Revolutionizing Functional Immune Cell Screening and Therapy Development with the Beacon Platform
Optofluidic
Speaker: Robert Carnahan, PhD, Associate Director, Vanderbilt Vaccine Center | Lauren Williamson, PhD, Research Assistant Professor, Vanderbilt University
Therapeutic Antibody Discovery: Selecting Effective Candidates for Emerging Viral Threats
Optofluidic
Speaker: Dr. Kate Malecek, Director of Beacon Center for Single Cell Biology at Caltech
Multiplexed and Quantitative Assays for Enhancing Antibody Discovery
Optofluidic
Speaker:
Vikram Devgan, PhD, Vice President of Global Marketing, BCA | Stefan Eichmรผller, PhD, Apl. Professor, Head of the Research Group GMP & T Cell Therapy, Qualified Person German Cancer Research Center (DKFZ) | Anthony E. Zamora, PhD, Assistant Professor, Medical College of Wisconsin, Department of Medicine, Division of Hematology & Oncology, and Department of Microbiology & Immunology | Franรงois Romagnรฉ, Scientific Director MImAbs | Xiaoxiao Wang, PhD., Vice President of Antibody Discovery and ADC Platform, Nona Bioscience | Shu Wang, Ph.D., Principal Investigator at Incyte
Roundtable: Understand the Life of Single Cells
Optofluidic
Speaker: Shu Wang, Ph.D., Principal Investigator at Incyte
Development of an On-Chip Binding Assay to Select Clones Producing High Quality Bispecific Antibodies
Optofluidic
Speaker: Franรงois Romagnรฉ, Scientific Director MImAbs
Antibody and Cell Therapy Development: The Life of Single Cells on Beaconยฎ Platform
Optofluidic
Speaker: Anthony E. Zamora, PhD, Assistant Professor, Medical College of Wisconsin, Department of Medicine, Division of Hematology & Oncology, and Department of Microbiology & Immunology
Leveraging Real-Time Biology to Streamline the Discovery, Validation, and Translation of Cell-Based Therapies for Cancer
Optofluidic
Speaker: Stefan Eichmรผller, PhD, Apl. Professor, Head of the Research Group GMP & T Cell Therapy, Qualified Person German Cancer Research Center (DKFZ), D210, Im Neuenheimer Feld 280, Heidelberg
Identification of Tumor-Reactive T Cell Receptors Through Functional Single Cell Interaction Analyses for Personalized T Cell Therapy
Optofluidic
Speaker: Vikram Devgan, PhD, Vice President of Global Marketing, Bruker Cellular Analysis
Harnessing the Power of the Beacon Platform to Accelerate Antibody and Cell Therapy Development
Optofluidic
Speaker: Xiaoxiao Wang, PhD., Vice President of Antibody Discovery and ADC Platform, Nona Bioscience
Full Human Antibody Discovery with Beaconยฎ and Harbour Miceยฎ
Optofluidic
Speaker: Vincent Pai, Associate Director, Product Management, Bruker Cellular Analysis
Building Broader B Cell Diversity for Better Monoclonal Antibody Discovery
Optofluidic
Speaker: Patrick Schmidt, PhD, Senior Research Associate, National Center for Tumor Diseases (NCT), German Center Research Center (DKFZ)
How to Speed Up the Cell Therapy Development Processes: Advancing CAR T Manufacturing Using Single Cell Analysis